Neeta Somaiah Selected Research

Constipation

10/2023	Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study.
10/2020	Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neeta Somaiah Research Topics

Disease

49	Neoplasms (Cancer) 05/2024 - 07/2010
36	Sarcoma (Soft Tissue Sarcoma) 05/2024 - 01/2012
13	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2024 - 02/2009
12	Liposarcoma 02/2024 - 05/2013
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2018 - 11/2009
7	Disease Progression 01/2024 - 12/2017
6	Testicular Neoplasms (Testicular Cancer) 01/2023 - 01/2014
5	Nausea 01/2023 - 12/2017
5	Fatigue 01/2023 - 12/2017
4	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 12/2017
3	Diarrhea 01/2023 - 12/2017
3	Hemangiosarcoma (Angiosarcoma) 10/2022 - 01/2022
3	Synovial Sarcoma (Synovioma) 01/2022 - 04/2015
3	Alveolar Soft Part Sarcoma 01/2022 - 01/2018
3	Leiomyosarcoma 01/2022 - 01/2017
3	Myxoid Liposarcoma 08/2017 - 04/2015
3	Lung Neoplasms (Lung Cancer) 01/2014 - 01/2011
2	Constipation 10/2023 - 10/2020
2	Anemia 01/2023 - 11/2021
2	Alopecia (Baldness) 01/2023 - 10/2020
2	Chordoma 10/2022 - 01/2022
2	Melanoma (Melanoma, Malignant) 05/2019 - 09/2018
2	Neoplasm Metastasis (Metastasis) 01/2018 - 04/2015
2	Cardiotoxicity 10/2017 - 01/2017
1	Pleural Effusion (Pleural Effusions) 01/2023
1	Perivascular Epithelioid Cell Neoplasms 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Leukopenia 01/2023
1	Muscle Cramp (Cramp) 01/2023
1	Myocarditis (Carditis) 01/2023
1	Neutropenia 01/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Retinoblastoma (Glioblastoma, Retinal) 01/2023
1	Wounds and Injuries (Trauma) 12/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Colitis 01/2022
1	Aggressive Fibromatosis (Desmoid) 01/2022
1	Abdominal Pain (Pain, Abdominal) 11/2021
1	Pain (Aches) 08/2021
1	Phyllodes Tumor (Cystosarcoma Phylloides) 04/2021

Drug/Important Bio-Agent (IBA)

9	ripretinibIBA 02/2024 - 10/2020
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2010
7	Immune Checkpoint InhibitorsIBA 05/2024 - 12/2017
6	AntigensIBA 01/2023 - 01/2014
5	Imatinib Mesylate (Gleevec)FDA Link 01/2024 - 02/2009
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2011
5	pazopanib FDA Link 10/2022 - 11/2017
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2017
4	selinexorIBA 01/2023 - 08/2021
3	Phosphotransferases (Kinase)IBA 01/2023 - 01/2017
3	Monoclonal AntibodiesIBA 01/2023 - 03/2014
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2016
3	pembrolizumabIBA 01/2023 - 09/2018
3	Gemcitabine FDA Link 01/2023 - 01/2021
3	VimentinIBA 01/2018 - 03/2014
2	NivolumabIBA 02/2024 - 09/2018
2	IpilimumabIBA 02/2024 - 09/2018
2	Sunitinib (Sutent)FDA Link 01/2024 - 10/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2017
2	Docetaxel (Taxotere)FDA Link 01/2023 - 01/2021
2	TroponinIBA 01/2023 - 01/2017
2	CytokinesIBA 01/2023 - 12/2017
2	palbociclibIBA 01/2022 - 01/2017
2	Ifosfamide FDA LinkGeneric 04/2021 - 10/2017
2	VaccinesIBA 11/2020 - 12/2017
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 01/2014
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 04/2024
1	avapritinibIBA 02/2024
1	PlacebosIBA 11/2023
1	Exportin 1 ProteinIBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	AlbuminsIBA 01/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	A-Form DNA (A-DNA)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	abemaciclibIBA 01/2023
1	eribulin FDA Link 01/2023
1	Sirolimus (Rapamycin)FDA Link 01/2023
1	trans-sodium crocetinate (crocetin)IBA 01/2023
1	MTOR InhibitorsIBA 01/2023
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2022
1	tremelimumabIBA 01/2022
1	Cyclin-Dependent Kinase 4IBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	durvalumabIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Lipase (Acid Lipase)FDA Link 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Vinca AlkaloidsIBA 01/2022
1	Recombinant ProteinsIBA 11/2020

Therapy/Procedure

37	Therapeutics 12/2023 - 01/2012
10	Drug Therapy (Chemotherapy) 01/2023 - 07/2010
9	Immunotherapy 01/2022 - 01/2014
5	Radiotherapy 02/2024 - 01/2018
5	Biological Therapy 01/2014 - 07/2010
3	Neoadjuvant Therapy 02/2024 - 04/2015
3	Investigational Therapies (Experimental Therapy) 01/2023 - 06/2017
2	Precision Medicine 01/2022 - 08/2017
1	Duration of Therapy 11/2021